ASHP Therapeutic Position Statement on the Cessation of Tobacco Use
- 1 February 2009
- journal article
- Published by Oxford University Press (OUP) in American Journal of Health-System Pharmacy
- Vol. 66 (3), 291-307
- https://doi.org/10.2146/ajhp070303
Abstract
No abstract availableThis publication has 40 references indexed in Scilit:
- Trends in nicotine yield in smoke and its relationship with design characteristics among popular US cigarette brands, 1997 2005Tobacco Control, 2007
- Drug interactions with smokingAmerican Journal of Health-System Pharmacy, 2007
- Tobacco-related disease mortality among men who switched from cigarettes to spit tobaccoTobacco Control, 2007
- The neurobiological basis for partial agonist treatment of nicotine dependence: vareniclineInternational Journal Of Clinical Practice, 2006
- Two large prospective studies of mortality among men who use snuff or chewing tobacco (United States)Cancer Causes & Control, 2005
- Tobacco cessation counseling: Pharmacists’ opinions and practicesPatient Education and Counseling, 2005
- Safety and effectiveness of transdermal nicotine patch in smokers admitted with acute coronary syndromesThe American Journal of Cardiology, 2005
- Mortality in relation to smoking: 50 years' observations on male British doctorsBMJ, 2004
- Reviews of evidence regarding interventions to reduce tobacco use and exposure to environmental tobacco smoke11The names and affiliations of the Task Force members are listed in the front of this supplement and at www.thecommunityguide.org.American Journal of Preventive Medicine, 2001
- Drug Interactions with Tobacco SmokingClinical Pharmacokinetics, 1999